ATR and cancer: Based on the results presented here, it is possible that interfering with the ISR may also overcome the stalling in DNA replication, perhaps enhancing the vulnerability of cancer cells toward drugs that provoke replication stress, e.g., nucleoside analogs or ATR inhibitors6.